The motion: This house believes that efavirenz should remain as an option to treat HIV in the UK
For the motion: Dr Sarah Pett
MRC Clinical Trials Unit, London
Against the motion: Dr Alejandro Arenas-Pinto
MRC Clinical Trials Unit, London
Click here to go back to all presentations.